▶주메뉴 바로가기
▶본문 바로가기
Shares of Kolon Group ’s bio affiliates plummeted after South Korea’s drug authorities canceled the license for gene therapy drug Invossa on May 28. According to the Ministry of Food and Drug Safe...
Korean new drug developer Syntekabio is preparing to go public, after receiving approval for a drug candidate from CJ Healthcare, according to industry sources on May 20. The company has picked KB S...
Prosecutors raided a task force office of Samsung Electronics on May 16 as part of an investigation into allegations that Samsung Group may have ordered accounting fraud by its biopharmaceutical unit...
More than 350 individuals who own stocks of Samsung BioLogics have filed a damage suit against the Samsung Group unit over its alleged accounting fraud, judicial officials said on May 13. In the ...
Celltrion Healthcare, an affiliate of major biopharmaceutical firm Celltrion, had the highest average salary among listed firms in South Korea in 2018, data showed on May 7. The firm, which handl...
A local private equity firm Wired Partners is considering joining the bid for acquiring Kyung Nam Pharm , a local drug maker known for its vitamin supplement Lemona, according to industry sources o...
South Korea’s Boryung Pharmaceutical announced on May 2 that it has launched its flagship hypertension drug Kanarb in the Philippines. “With our experience of Kanarb’s success in Korea, we aim to ...
Major biosimilar manufacturer Celltrion ranked at the top among local companies last year in terms of R&D-to-sales ratio, industry data showed on May 1. According to the data by market tracker CE...
More and more South Korean pharmaceutical conglomerates are showing interest in funding small bio companies, as they see some merits in doing so. According to the annual reports of local pharma comp...
Celltrion said on April 29 that it has won approval from the US Food and Drug Administration for its antibiotic generic in the United States. Linezolid is expected to go on sale in the US by the ...
Daewoong Pharmaceutical‘s botulinum toxin Nabota received a positive opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), on April 26. The CHMP opinion is...
L&K Biomed is at risk of being delisted by bourse operator Korea Exchange, according to industry sources on April 24. The South Korean health care company’s stock trading has been suspended, as an e...
South Korean pharmaceutical company Boryung Pharmaceutical announced on April 23 that it has established a new production facility in Yesan, South Chungcheong Province. The new site in Yesan, whic...
South Korean bio company OliPass is preparing to go public by the end of the year, according to sources on April 23. Preparing to start the initial public offering process, the company has picked Mi...
South Korean bio startup MitoImmune Therapeutics announced on April 22 that it has closed its series A round after raising 12 billion won ($10.5 million). Four investors -- the state-run Korea Devel...
Bithumb, Yeogi Eottae, HanaTour indicted for data leak
Samsung Galaxy Fold is now ready for launch: Samsung Display exec
KTB Securities Thailand seeks listing on solid profits
S.M. Entertainment pressed to answer activist shareholder’s demands
Goldman Sachs lowers growth forecast for S. Korea, expects two rates cuts
SK hynix’s new China plant to stay idle over Huawei fallout
Taxi-sharing app operator Kornatus snaps W1.2b funds
Samsung Display continues to lead in mobile market: IHS
June 20, 2019
